108 related articles for article (PubMed ID: 2972816)
1. Comparison of the clearance of technetium-99m MAG3 and iodine-131 OIH.
Kim CK; Stritzke P; Goldsmith SJ
J Nucl Med; 1988 Nov; 29(11):1878-9. PubMed ID: 2972816
[No Abstract] [Full Text] [Related]
2. Effects of altered physiologic states on clearance and biodistribution of technetium-99m MAG3, iodine-131 OIH, and iodine-125 iothalamate.
Taylor A; Eshima D
J Nucl Med; 1988 May; 29(5):669-75. PubMed ID: 2967354
[TBL] [Abstract][Full Text] [Related]
3. Comparison of technetium-99m MAG3 kit with HPLC-purified technetium-99m MAG3 and OIH in rats.
Coveney JR; Robbins MS
J Nucl Med; 1987 Dec; 28(12):1881-7. PubMed ID: 2960790
[TBL] [Abstract][Full Text] [Related]
4. Technetium-99m-MAG3 versus iodine-123-OIH: renal clearance and distribution volume as measured by a constant infusion technique.
Prenen JA; de Klerk JM; van het Schip AD; van Rijk PP
J Nucl Med; 1991 Nov; 32(11):2057-60. PubMed ID: 1834812
[TBL] [Abstract][Full Text] [Related]
5. Radiation dosimetry for technetium-99m-MAG3, technetium-99m-DTPA, and iodine-131-OIH based on human biodistribution studies.
Stabin M; Taylor A; Eshima D; Wooter W
J Nucl Med; 1992 Jan; 33(1):33-40. PubMed ID: 1530968
[TBL] [Abstract][Full Text] [Related]
6. Prospective validation of a single sample technique to determine technetium-99m-MAG3 clearance.
Taylor A; Corrigan P; Eshima D; Folks R
J Nucl Med; 1992 Sep; 33(9):1620-2. PubMed ID: 1387682
[TBL] [Abstract][Full Text] [Related]
7. Technetium-99m MAG-3 clearances after captopril in experimental renovascular hypertension.
Lee HB; Blaufox MD
J Nucl Med; 1989 May; 30(5):666-71. PubMed ID: 2523959
[TBL] [Abstract][Full Text] [Related]
8. Clinical comparison of I-131 orthoiodohippurate and the kit formulation of Tc-99m mercaptoacetyltriglycine.
Taylor A; Ziffer JA; Steves A; Eshima D; Delaney VB; Welchel JD
Radiology; 1989 Mar; 170(3 Pt 1):721-5. PubMed ID: 2521734
[TBL] [Abstract][Full Text] [Related]
9. [99mTc-MAG3 and 131I-OIH in patients with kidney insufficiency and with normal kidneys].
Keske U; Cordes M; Wilfling M; Hunger J; Hosten N; Gahl G
Rofo; 1990 Mar; 152(3):287-92. PubMed ID: 2157251
[TBL] [Abstract][Full Text] [Related]
10. Technetium-99m MAG3, a comparison with iodine-123 and iodine-131 orthoiodohippurate, in patients with renal disorders.
Jafri RA; Britton KE; Nimmon CC; Solanki K; Al-Nahhas A; Bomanji J; Fettich J; Hawkins LA
J Nucl Med; 1988 Feb; 29(2):147-58. PubMed ID: 2964516
[TBL] [Abstract][Full Text] [Related]
11. [A comparison of different methods of calculating clearances using 99mTc-mercaptoacetyltriglycine and 123I- or 131I-ortho-iodohippuric acid].
Keske U; Cordes M; Hosten N; Roll D; Hunger J; Felix R
Nuklearmedizin; 1990 Jun; 29(3):93-100. PubMed ID: 2144045
[TBL] [Abstract][Full Text] [Related]
12. Comparison of technetium-99m MAG3 with iodine-131 hippuran by a simultaneous dual channel technique.
Russell CD; Thorstad B; Yester MV; Stutzman M; Baker T; Dubovsky EV
J Nucl Med; 1988 Jul; 29(7):1189-93. PubMed ID: 2969040
[TBL] [Abstract][Full Text] [Related]
13. The difference in clearance between kit-prepared technetium-99m-MAG3 and radioiodinated hippuric acid.
Bubeck B; Brandau W
J Nucl Med; 1991 Aug; 32(8):1642-4. PubMed ID: 1831230
[No Abstract] [Full Text] [Related]
14. The kidney: imaging with Tc-99m mercaptoacetyltriglycine, a technetium-labeled analog of iodohippurate.
Russell CD; Thorstad BL; Stutzman ME; Yester MV; Fowler D; Dubovsky EV
Radiology; 1989 Aug; 172(2):427-30. PubMed ID: 2526350
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of the renal clearance of 99mTc-DTPA and inulin, 131I-hippurate and PAH and creatinine clearance in Wistar rats].
Hagemann J; Su LM; Strangfeld D; Schürer M; Siewert H; Pietsch R; Kruse I; Priem F
Radiobiol Radiother (Berl); 1988; 29(4):497-505. PubMed ID: 3055016
[No Abstract] [Full Text] [Related]
16. Animal evaluation of technetium-99m triamide mercaptide complexes as potential renal imaging agents.
Eshima D; Taylor A; Fritzberg AR; Kasina S; Hansen L; Sorenson JF
J Nucl Med; 1987 Jul; 28(7):1180-6. PubMed ID: 2955085
[TBL] [Abstract][Full Text] [Related]
17. Quantitation of renal function with technetium-99m MAG3.
Russell CD; Thorstad BL; Yester MV; Stutzman M; Dubovsky EV
J Nucl Med; 1988 Dec; 29(12):1931-3. PubMed ID: 2973517
[TBL] [Abstract][Full Text] [Related]
18. Clinical comparison of technetium-99m-EC, technetium-99m-MAG3 and iodine-131-OIH in renal disorders.
Kabasakal L; Turoğlu HT; Onsel C; Ozker K; Uslu I; Atay S; Cansiz T; Sönmezoğlu K; Altiok E; Isitman AT
J Nucl Med; 1995 Feb; 36(2):224-8. PubMed ID: 7830118
[TBL] [Abstract][Full Text] [Related]
19. Preliminary results comparing OIH, 99mTc-MAG3 and iothalamate in a rat model of renal ischemia.
Eshima D; Greene J; Taylor A
Contrib Nephrol; 1990; 79():24-7. PubMed ID: 2146085
[No Abstract] [Full Text] [Related]
20. Comparison of 99mTc-mercaptoacetyltriglycine and [131I]-o-iodohippurate elimination in perfused rat kidney.
Trejtnar F; Laznicek M; Laznickova A
Nucl Med Biol; 2003 Jan; 30(1):45-9. PubMed ID: 12493542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
